Sembragiline
Sembragiline (EVT 302) is a potent, selective and reversible monoamine oxidase B (MAO-B) inhibitor. Sembragiline reduces the metabolism of dopamine and other amine neurotransmitters by inhibiting the activity of the MAO-B enzyme, thereby potentially increasing the concentration of these neurotransmitters in the brain. Inhibition of the MAO-B enzyme also reduces the formation of toxic reactive oxygen species (ROS) that play a role in the pathological process of AD. Sembragiline has good oral activity and blood-brain barrier permeability. Sembragiline can be used in studies of AD, especially in patients with AD who show increased MAO-B activity[1].
Product Specifications
CAS Number
676479-06-4
Product Name Alternative
EVT 302; RG1577; RO4602522
UNSPSC
12352005
Target
Monoamine Oxidase; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sembragiline.html
Smiles
CC(N[C@@H](C1)CN(C2=CC=C(OCC3=CC=CC(F)=C3)C=C2)C1=O)=O
Molecular Formula
C19H19FN2O3
Molecular Weight
342.36
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Uncoated Mouse NGF (Nerve growth factor) ELISA Kit
Uncoated Mouse NGF (Nerve growth factor) ELISA Kit
CDKN1A interacting zinc finger protein 1 (CIZ1) (NM_001131016) Human Over-expression Lysate
1,2,4-Benzenetricarboxylic Acid 1-(2-ethylhexyl) Ester
